Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes Mellitus

home / publications / supplement / a515_oct14_diabetesmellitus

Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes Mellitus

Varun U. Ektare, BPharm, MPH;Janice M. S. Lopez, PharmD, MPH;Silas C. Martin, MS;Dipen A. Patel, BPharm, PhD;Marcia F. T. Rupnow, PhD;Marc F. Botteman, MSc, MA

October 26th 2014

ArticleARTICLES

Participating Faculty: Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes Mellitus

Varun U. Ektare, BPharm, MPH;Janice M. S. Lopez, PharmD, MPH;Silas C. Martin, MS;Dipen A. Patel, BPharm, PhD;Marcia F. T. Rupnow, PhD;Marc F. Botteman, MSc, MA

October 26th 2014

ArticleAUTHOR INDEX

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions